Miscarriage · assisted reproduction technology cycles
1 finding from 1 review
Oocyte pick‐up cancellation ‐ Normo‐responders (Dydrogesterone 20 mg versus Micronised progesterone 100 mg) ‐ Own oocytes ‐ Early phase stimulation protocol · assisted reproduction technology cycles
Summary of findings table ‐ Progestogen 1 showed no clear difference in oocyte pick‐up cancellation ‐ Normo‐responders (Dydrogesterone 20 mg… compared with progestogen 2 (moderate certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproduction technology cycles
Summary of findings table ‐ Progestogen 1 showed no clear difference in clinical pregnancy ‐ Normo‐responders (MPA 10 mg versus… compared with progestogen 2 (moderate certainty).
1 finding from 1 review
Miscarriage · assisted reproduction technology cycles
Summary of findings table ‐ Progestogen 1 showed no clear difference in miscarriage ‐ Miscarriage per randomised woman ‐ Normo‐responders… compared with progestogen 2 (low certainty).
1 finding from 1 review
MII oocytes · assisted reproduction technology cycles
1 finding from 1 review
Total dose of gonadotropins · assisted reproduction technology cycles
1 finding from 1 review
Moderate or severe OHSS · assisted reproduction technology cycles
1 finding from 1 review
Live birth or ongoing pregnancy ‐ Poor‐responders (MPA 10 mg versus GnRH antagonists) ‐ Own oocytes ‐ Early phase stimulation protocol · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in live birth or ongoing pregnancy ‐ Poor‐responders (MPA 10 mg versus… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Cumulative pregnancy rate · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Premature LH surge ‐ Donor oocytes ‐ Normoresponders ‐ Early phase stimulation protocol ‐ Fresh embryo transfer · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
No studies included for any outcomes · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of pain · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as dysmenorrhoea ‐ 6 months · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · patients with pain associated with endometriosis
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · patients with pain associated with endometriosis
1 finding from 1 review
No studies included with only low risk of bias · patients with pain associated with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
GnRHas vs gestrinone Percentage change values ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
2 findings from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Anterior‐posterior spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Lateral spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review